- Home
- PYPD vs JZXN Comparison
PYPD vs JZXN Comparison
Compare PYPD & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- JZXN
- Stock Information
- Founded
- PYPD 2008
- JZXN 2017
- Country
- PYPD Israel
- JZXN China
- Employees
- PYPD N/A
- JZXN N/A
- Industry
- PYPD Medical/Dental Instruments
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- PYPD Health Care
- JZXN Consumer Discretionary
- Exchange
- PYPD Nasdaq
- JZXN Nasdaq
- Market Cap
- PYPD 16.3M
- JZXN 15.3M
- IPO Year
- PYPD 2020
- JZXN 2021
- Fundamental
- Price
- PYPD $3.47
- JZXN $1.31
- Analyst Decision
- PYPD Buy
- JZXN
- Analyst Count
- PYPD 2
- JZXN 0
- Target Price
- PYPD $12.00
- JZXN N/A
- AVG Volume (30 Days)
- PYPD 4.6K
- JZXN 26.9K
- Earning Date
- PYPD 11-06-2024
- JZXN 10-15-2024
- Dividend Yield
- PYPD N/A
- JZXN N/A
- EPS Growth
- PYPD N/A
- JZXN N/A
- EPS
- PYPD N/A
- JZXN N/A
- Revenue
- PYPD N/A
- JZXN $7,597,423.00
- Revenue This Year
- PYPD N/A
- JZXN N/A
- Revenue Next Year
- PYPD N/A
- JZXN N/A
- P/E Ratio
- PYPD N/A
- JZXN N/A
- Revenue Growth
- PYPD N/A
- JZXN 81.94
- 52 Week Low
- PYPD $2.95
- JZXN $1.00
- 52 Week High
- PYPD $9.20
- JZXN $67.60
- Technical
- Relative Strength Index (RSI)
- PYPD 46.98
- JZXN 39.30
- Support Level
- PYPD $3.37
- JZXN $1.36
- Resistance Level
- PYPD $3.65
- JZXN $1.76
- Average True Range (ATR)
- PYPD 0.17
- JZXN 0.17
- MACD
- PYPD -0.00
- JZXN -0.01
- Stochastic Oscillator
- PYPD 36.36
- JZXN 4.84
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.